Characteristics and outcomes of patients hospitalized for infection with Influenza A, SARS-CoV-2 or respiratory syncytial virus in the season 2023/2024 in a large German primary care centre
Between 8/2023 to 2/2024, a large population of patients hospitalized due to respiratory tract infection, showed relative contributions of SARS-CoV-2, Influenza A or RSV similar to those in 2022/23. The findings underline that in both, adults and children, RSV posed a relatively higher clinical risk than Influenza A and SARS-CoV-2, though absolute numbers remained highest for SARS-CoV-2.
Authors
- Christian Fischer (ORCID: https://orcid.org/0000-0002-5023-1080)
- Stephan Budweiser (ORCID: https://orcid.org/0000-0003-2456-8410)
- Peter J. Alter (ORCID: https://orcid.org/0000-0002-2115-1743)
- Rudolf A. Jörres (ORCID: https://orcid.org/0000-0002-9782-1117)
- Lena Wiechert
- Kathrin Kahnert (ORCID: https://orcid.org/0000-0001-9633-3368)
- Stefan Engelhardt (ORCID: https://orcid.org/0000-0001-5378-8661)
Institutions
- TUM Klinikum (DE)
- University Hospital Regensburg (DE)
- RoMed Kliniken (DE)
- German Center for Lung Research (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1186/s40001-024-02096-9
- Citations
- 5
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.93